Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 13, 2024
Worldwide Clinical Trials, a global full-service contract research organization (CRO), has released results of a recent industry survey. The report examines changing perceptions about large and midsize CROs within the pharmaceutical and biotech ...
read more
Tuesday, February 13, 2024
Alcami Corporation announced the strategic expansion of its sterile fill/finish manufacturing capacity with the addition of a new sterile fill/finish line with isolator and two lyophilizers at its existing Charleston, SC manufacturing campus.
read more
Tuesday, February 13, 2024
Amneal Pharmaceuticals, Inc announced that it has provided a Complete Response resubmission to the FDA for IPX203, a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules for the treatment of Parkinson’s disease (PD).
read more
Tuesday, February 13, 2024
Abzena has announced the launch of its new analytical platform, LabZient™. The standardized and automated platform streamlines the assessment and validation of large molecules, which significantly reduces drug development timelines and resource costs...
read more
Tuesday, February 13, 2024
Catalent, Inc. and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, announced that they have entered into a merger agreement under which Novo Holdings will acquire ...
read more
Wednesday, February 14, 2024
PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of alpha-emitting radioisotopes, announced the signing of a capacity reservation agreement with Bayer for the supply of actinium-225 (225Ac) starting in ...
read more
Wednesday, February 14, 2024
The PPD clinical research business of Thermo Fisher Scientific Inc., is adding mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
read more
Friday, February 16, 2024
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, announced the Aseptic Process Simulation (APS) qualification of its ...
read more
Friday, February 16, 2024
Catalyst Clinical Research announced that Nik Morton, the company's president and COO, assumed its CEO role on 12 February 2024. Mr. Morton joined Catalyst as its COO in 2022. Mr. Morton moved into his new position while Nick Dyer, Catalyst's former ...
read more
Tuesday, February 20, 2024
RSSL, a pharmaceutical contract research organization, has announced plans to launch its new Innovation Hub, a dedicated platform to help small- and medium-sized biotech organizations de-risk and accelerate the development of cutting-edge products.
read more
Tuesday, February 20, 2024
AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering.
read more
Tuesday, February 20, 2024
National Resilience, Inc. (Resilience) announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network. By scaling this capacity, Resilience aims to provide over 200 million units to its ...
read more
Wednesday, February 21, 2024
Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, ...
read more
Wednesday, February 21, 2024
Worldwide Clinical Trials has expanded the pharmacy at its Clinical Pharmacology Unit (CPU) in San Antonio, Texas. Completed in January 2024, the expanded pharmacy provides Worldwide’s customers with streamlined processes, as well as decreased ...
read more
Thursday, February 22, 2024
Immunocore Holdings announced that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb to investigate Immunocore’s ImmTAC bispecific TCR (T cell receptor) candidate targeting PRAME HLA-A02, IMC-F106C, in ...
read more